Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusal increased the share of aluminum scrap in foundry alloys to 30%

11/9/23 RUAL

EBRD sells 4.9% stake in Bank Saint Petersburg

11/9/23 BSPB

Investors are likely to be able to sell foreign securities on the SPB Exchange

11/9/23 SPBE

Magnit closed the deal on the purchase of marketplace KazanExpress

11/9/23 MGNT

VK reported for 9 months of 2023

11/9/23 VKCO

Number of trips to Whoosh for 10 months in 2023 has increased by 89%

11/9/23 WUSH

Yuzhuralzoloto intends to hold an IPO by the end of November

11/9/23 UGLD

Rostelecom reported for 9 months of 2023 by IFRS

11/9/23 RTKM

Sony reported for 6 months of fiscal year 2023

11/9/23 SONY

Softline's turnover grew by 15.7%

11/9/23 SOFL